Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.9 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |